Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEY. (2024)

First Author: Nangaku M
Attributed to:  Randomised trials in cardiovascular and metabolic disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10157-024-02489-4

PubMed Identifier: 38643286

Publication URI: http://europepmc.org/abstract/MED/38643286

Type: Journal Article/Review

Volume: 28

Parent Publication: Clinical and experimental nephrology

Issue: 6

ISSN: 1342-1751